BNX Bionex Inv.

RNS Number:9347U
Bionex Investments PLC
03 February 2004

Bionex Investments plc


3 February 2004



Strategic Review and Directorate Change


Following a strategic review the Board has concluded that, for the time being,
funds currently available to the Company will be utilised in continuing to
support those companies in the portfolio that the Board consider to be capable
of realising value in the medium term, rather than investing in new unquoted
opportunities.  The Board will seek to optimise short term returns by continuing
with the Company's trading activities in quoted securities.



In view of this strategic change and the consequent reduction in the Company's
day to day activities, Graham Wylie, Chairman and Chief Executive, will be
leaving the Company and therefore resigns from the Board with immediate effect.



The Board would like to express their thanks to Graham for all his efforts in
establishing the business and in taking the Company to flotation and beyond and
wish him well for the future.



Christopher Roberts, currently Finance Director, has agreed to take over as
Executive Chairman.



Enquiries:

Christopher Roberts                        020 7937 4445
Bionex Investments plc

Peter Jackson                              020 7397 3000
W H Ireland Limited


                      This information is provided by RNS
            The company news service from the London Stock Exchange
END

STRMGGGZMFVGDZM

Bionex (LSE:BNX)
과거 데이터 주식 차트
부터 1월(1) 2025 으로 2월(2) 2025

Bionex (LSE:BNX)
과거 데이터 주식 차트
부터 2월(2) 2024 으로 2월(2) 2025